Literature DB >> 33602128

Correlation between lung infection severity and clinical laboratory indicators in patients with COVID-19: a cross-sectional study based on machine learning.

Xingrui Wang1,2, Qinglin Che3, Xiaoxiao Ji1, Xinyi Meng1, Lang Zhang1, Rongrong Jia1, Hairong Lyu1, Weixian Bai1, Lingjie Tan1, Yanjun Gao4,5.   

Abstract

BACKGROUND: Coronavirus disease 2019 (COVID-19) has caused a global pandemic that has raised worldwide concern. This study aims to investigate the correlation between the extent of lung infection and relevant clinical laboratory testing indicators in COVID-19 and to analyse its underlying mechanism.
METHODS: Chest high-resolution computer tomography (CT) images and laboratory examination data of 31 patients with COVID-19 were extracted, and the lesion areas in CT images were quantitatively segmented and calculated using a deep learning (DL) system. A cross-sectional study method was carried out to explore the differences among the proportions of lung lobe infection and to correlate the percentage of infection (POI) of the whole lung in all patients with clinical laboratory examination values.
RESULTS: No significant difference in the proportion of infection was noted among various lung lobes (P > 0.05). The POI of total lung was negatively correlated with the peripheral blood lymphocyte percentage (L%) (r = - 0.633, P < 0.001) and lymphocyte (LY) count (r = - 0.555, P = 0.001) but positively correlated with the neutrophil percentage (N%) (r = 0.565, P = 0.001). Otherwise, the POI was not significantly correlated with the peripheral blood white blood cell (WBC) count, monocyte percentage (M%) or haemoglobin (HGB) content. In some patients, as the infection progressed, the L% and LY count decreased progressively accompanied by a continuous increase in the N%.
CONCLUSIONS: Lung lesions in COVID-19 patients are significantly correlated with the peripheral blood lymphocyte and neutrophil levels, both of which could serve as prognostic indicators that provide warning implications, and contribute to clinical interventions in patients.

Entities:  

Keywords:  Artificial intelligence; COVID-19; Deep learning; Infection severity; Lymphocyte; Neutrophil; SARS-CoV-2

Mesh:

Year:  2021        PMID: 33602128      PMCID: PMC7891484          DOI: 10.1186/s12879-021-05839-9

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  32 in total

1.  IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections.

Authors:  Kapil Bahl; Sung-Kwon Kim; Claudia Calcagno; Dario Ghersi; Roberto Puzone; Franco Celada; Liisa K Selin; Raymond M Welsh
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

2.  Morphological aspects of glucocorticoid-induced cell death in human lymphoblastoid cells.

Authors:  A M Robertson; C C Bird; A W Waddell; A R Currie
Journal:  J Pathol       Date:  1978-11       Impact factor: 7.996

3.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

4.  CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin.

Authors:  Akihiko Ichikawa; Keiji Kuba; Masayuki Morita; Shinsuke Chida; Hiroyuki Tezuka; Hiromitsu Hara; Takehiko Sasaki; Toshiaki Ohteki; V Marco Ranieri; Claudia C dos Santos; Yoshihiro Kawaoka; Shizuo Akira; Andrew D Luster; Bao Lu; Josef M Penninger; Stefan Uhlig; Arthur S Slutsky; Yumiko Imai
Journal:  Am J Respir Crit Care Med       Date:  2012-11-09       Impact factor: 21.405

Review 5.  Glucocorticosteroid therapy: mechanisms of action and clinical considerations.

Authors:  A S Fauci; D C Dale; J E Balow
Journal:  Ann Intern Med       Date:  1976-03       Impact factor: 25.391

Review 6.  Artificial intelligence in radiology.

Authors:  Ahmed Hosny; Chintan Parmar; John Quackenbush; Lawrence H Schwartz; Hugo J W L Aerts
Journal:  Nat Rev Cancer       Date:  2018-08       Impact factor: 60.716

7.  Role of vascular cell adhesion molecules and leukocyte apoptosis in the lymphopenia and thrombocytopenia of patients with severe acute respiratory syndrome (SARS).

Authors:  Rong-Fu Chen; Jen-Chieh Chang; Wen-Tien Yeh; Chen-Hsiang Lee; Jien-Wei Liu; Hock-Liew Eng; Kuender D Yang
Journal:  Microbes Infect       Date:  2005-08-10       Impact factor: 2.700

8.  Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.

Authors:  Jesús Villar; Carlos Ferrando; Domingo Martínez; Alfonso Ambrós; Tomás Muñoz; Juan A Soler; Gerardo Aguilar; Francisco Alba; Elena González-Higueras; Luís A Conesa; Carmen Martín-Rodríguez; Francisco J Díaz-Domínguez; Pablo Serna-Grande; Rosana Rivas; José Ferreres; Javier Belda; Lucía Capilla; Alec Tallet; José M Añón; Rosa L Fernández; Jesús M González-Martín
Journal:  Lancet Respir Med       Date:  2020-02-07       Impact factor: 30.700

9.  Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.

Authors:  Michael Letko; Andrea Marzi; Vincent Munster
Journal:  Nat Microbiol       Date:  2020-02-24       Impact factor: 17.745

10.  Abnormal lung quantification in chest CT images of COVID-19 patients with deep learning and its application to severity prediction.

Authors:  Fei Shan; Yaozong Gao; Jun Wang; Weiya Shi; Nannan Shi; Miaofei Han; Zhong Xue; Dinggang Shen; Yuxin Shi
Journal:  Med Phys       Date:  2021-03-09       Impact factor: 4.506

View more
  6 in total

1.  Machine Learning and Lean Six Sigma to Assess How COVID-19 Has Changed the Patient Management of the Complex Operative Unit of Neurology and Stroke Unit: A Single Center Study.

Authors:  Giovanni Improta; Anna Borrelli; Maria Triassi
Journal:  Int J Environ Res Public Health       Date:  2022-04-26       Impact factor: 4.614

2.  The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan.

Authors:  Ali Zaid; Adam Taylor; Suresh Mahalingam; Xiang Liu; Helen Mostafavi; Wern Hann Ng; Joseph R Freitas; Nicholas J C King
Journal:  mBio       Date:  2022-04-14       Impact factor: 7.786

Review 3.  After the virus has cleared-Can preclinical models be employed for Long COVID research?

Authors:  Ethan B Jansen; Spencer N Orvold; Cynthia L Swan; Anthony Yourkowski; Brittany M Thivierge; Magen E Francis; Anni Ge; Melissa Rioux; Joseph Darbellay; John G Howland; Alyson A Kelvin
Journal:  PLoS Pathog       Date:  2022-09-07       Impact factor: 7.464

4.  Screening and assessment for post-acute COVID-19 syndrome (PACS), guidance by personal pilots and support with individual digital trainings within intersectoral care: a study protocol of a randomized controlled trial.

Authors:  Alina Dahmen; Franziska M Keller; Christina Derksen; Robin Rinn; Petra Becker; Sonia Lippke
Journal:  BMC Infect Dis       Date:  2022-08-15       Impact factor: 3.667

5.  Machine learning application for the prediction of SARS-CoV-2 infection using blood tests and chest radiograph.

Authors:  Richard Du; Efstratios D Tsougenis; Joshua W K Ho; Joyce K Y Chan; Keith W H Chiu; Benjamin X H Fang; Ming Yen Ng; Siu-Ting Leung; Christine S Y Lo; Ho-Yuen F Wong; Hiu-Yin S Lam; Long-Fung J Chiu; Tiffany Y So; Ka Tak Wong; Yiu Chung I Wong; Kevin Yu; Yiu-Cheong Yeung; Thomas Chik; Joanna W K Pang; Abraham Ka-Chung Wai; Michael D Kuo; Tina P W Lam; Pek-Lan Khong; Ngai-Tseung Cheung; Varut Vardhanabhuti
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

Review 6.  Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates.

Authors:  Marieke A Stammes; Ji Hyun Lee; Lisette Meijer; Thibaut Naninck; Lara A Doyle-Meyers; Alexander G White; H Jacob Borish; Amy L Hartman; Xavier Alvarez; Shashank Ganatra; Deepak Kaushal; Rudolf P Bohm; Roger le Grand; Charles A Scanga; Jan A M Langermans; Ronald E Bontrop; Courtney L Finch; JoAnne L Flynn; Claudia Calcagno; Ian Crozier; Jens H Kuhn
Journal:  Trends Mol Med       Date:  2021-12-07       Impact factor: 15.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.